NFKB1 and atherosclerosis: The canonical NF-κB signaling pathway is a mediator of the cellular inflammatory response, and aberrant activation of NF-κB is perhaps implicated in a spectrum of human diseases, including chronic inflammatory disease, atherosclerosis, and cancer [12].